EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSSVLG00005025036
Gene Symbol: GRIK5
1 Cross references
302 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSSVLG00005008510
Gene Symbol: GRM2
1 Cross references
276 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSSVLG00005013647
Gene Symbol: GRM3
1 Cross references
215 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSVLG00005010040
Gene Symbol: GRM4
1 Cross references
273 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSSVLG00005021581
Gene Symbol: GRM5
1 Cross references
272 Possible Orthologues:

Glutaminase

Ensembl ID : ENSSVLG00005001404
Gene Symbol: GLS
1 Cross references
305 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSSVLG00005025366
Gene Symbol: GSTP1
1 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSSVLG00005024717
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSSVLG00005013429
Gene Symbol: GSK3B
1 Cross references
241 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSSVLG00005025536
Gene Symbol: GNRHR
1 Cross references
454 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSSVLG00005015402
Gene Symbol: GHRHR
1 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSSVLG00005009108
Gene Symbol: GHSR
1 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).